Multi-parameter flow cytometry immunophenotyping distinguishes different stages of tuberculosis infection

Olivia Estévez1, Luis Anibarro2, Elina Garet1

  • 1CINBIO, Universidade de Vigo, Immunology Group, Campus universitario Lagoas, Marcosende, 36310 Vigo, Spain; Instituto de Investigación Sanitaria Galicia Sur (IIS-GS), Spain.

Insights

New blood biomarkers can help diagnose active tuberculosis (TB). Researchers found specific T-cell subsets and ratios in leukocytes differentiate active TB from latent infection or no TB exposure.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Biomarker Discovery

Background:

  • Accurate diagnosis of active tuberculosis (TB) is crucial for effective treatment and control.
  • Current diagnostic methods have limitations, necessitating the search for novel host biomarkers.
  • Distinguishing active TB from latent TB infection (LTBI) and uninfected individuals is a diagnostic challenge.

Purpose of the Study:

  • To identify novel host biomarkers in blood for differentiating active TB patients from uninfected (NoTBI) and latently infected contacts (LTBI).
  • To evaluate the diagnostic accuracy of identified biomarkers using multi-parameter flow cytometry.

Main Methods:

  • Blood cell counts were performed to analyze leukocyte populations.
  • Peripheral blood mononuclear cells (PBMCs) were isolated for multi-parameter flow cytometry.
  • Basal and Mycobacterium tuberculosis (Mtb)-stimulated lymphocyte distribution and expression were analyzed, with diagnostic accuracy assessed by Area Under the ROC Curve (AUC).

Main Results:

  • Active TB patients showed significantly higher Monocyte-to-lymphocyte and Neutrophil-to-lymphocyte ratios (AUC >0.8).
  • Differences in basal Th1/Th2 ratio, Th1-Th17, CD4+ Central Memory (TCM), and MAIT cells distinguished active TB from contact groups (AUC >0.7).
  • Mtb-stimulated CD4+ TCM cells expressing CD154 demonstrated higher accuracy than IFNγ in discriminating Mtb-specific activation.

Conclusions:

  • Specific leukocyte ratios and lymphocyte subsets serve as potential diagnostic biomarkers for tuberculosis.
  • The distribution of CD4+ TCM cells and their CD154 expression post-Mtb activation are highly promising for TB diagnosis.
Abstract